We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$14.5M
Cap. Flow
-$16.8M
Cap. Flow %
-15.73%
Top 10 Hldgs %
2.69%
Holding
2,904
New
705
Increased
558
Reduced
830
Closed
739

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$423K
2
GIS icon
General Mills
GIS
+$314K
3
MO icon
Altria Group
MO
+$234K
4
PX
Praxair Inc
PX
+$231K
5
ATR icon
AptarGroup
ATR
+$231K

Sector Composition

Rank Sector Weight
1 Industrials 15.12%
2 Healthcare 14.17%
3 Financials 13.11%
4 Consumer Discretionary 12.41%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
276
LKQ Corp
LKQ
$6.29B
$96K 0.09%
+2,902
New +$89.7K
SID icon
277
Companhia Siderúrgica Nacional
SID
$1.23B
$96K 0.09%
44,881
+10,363
+30% +$23.1K
VTTI
278
DELISTED
VTTI Energy Partners LP
VTTI
$96K 0.09%
4,891
+4,567
+1,410% +$88.1K
RHT
279
DELISTED
Red Hat Inc
RHT
$96K 0.09%
1,000
EW icon
280
Edwards Lifesciences
EW
$51.7B
$95K 0.09%
2,400
+1,500
+167% +$54.8K
GSK icon
281
GSK
GSK
$106B
$95K 0.09%
1,760
+1,200
+214% +$64K
MANH icon
282
Manhattan Associates
MANH
$11.4B
$95K 0.09%
1,977
-200
-9% -$9.48K
ODFL icon
283
Old Dominion Freight Line
ODFL
$44.9B
$95K 0.09%
+3,000
New +$88.3K
LDR
284
DELISTED
Landauer Inc
LDR
$95K 0.09%
1,816
+1,323
+268% +$68.1K
ABT icon
285
Abbott
ABT
$187B
$94K 0.09%
1,926
+1,500
+352% +$67.9K
HELE icon
286
Helen of Troy
HELE
$693M
$94K 0.09%
1,000
-200
-17% -$18.6K
MPC icon
287
Marathon Petroleum
MPC
$83.7B
$94K 0.09%
1,800
+1,300
+260% +$67.2K
PM icon
288
Philip Morris
PM
$295B
$94K 0.09%
800
NP
289
DELISTED
Neenah, Inc. Common Stock
NP
$94K 0.09%
+1,172
New +$91K
MDSO
290
DELISTED
Medidata Solutions, Inc.
MDSO
$94K 0.09%
1,201
-900
-43% -$62.7K
WNRL
291
DELISTED
Western Refining Logistics, LP
WNRL
$94K 0.09%
3,654
+940
+35% +$23.6K
SBUX icon
292
Starbucks
SBUX
$120B
$93K 0.09%
1,600
+1,000
+167% +$60.5K
VIVO
293
DELISTED
Meridian Bioscience Inc
VIVO
$93K 0.09%
+5,880
New +$84.7K
AWI icon
294
Armstrong World Industries
AWI
$7.84B
$92K 0.09%
+1,991
New +$89.3K
BURL icon
295
Burlington
BURL
$23.2B
$92K 0.09%
1,000
-1,000
-50% -$96.2K
CSTE icon
296
Caesarstone
CSTE
$79.5M
$92K 0.09%
2,621
+1,711
+188% +$64.1K
EME icon
297
Emcor
EME
$36B
$92K 0.09%
+1,400
New +$90.1K
EXP icon
298
Eagle Materials
EXP
$6.57B
$92K 0.09%
1,000
-500
-33% -$48K
VC icon
299
Visteon
VC
$2.78B
$92K 0.09%
+900
New +$88.9K
CNR
300
DELISTED
Cornerstone Building Brands, Inc.
CNR
$92K 0.09%
+5,525
New +$93.6K

Similar funds

Acrospire Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Acrospire Investment Management held 2,904 positions worth $107M, down 12% from $121M the previous quarter. Its ten largest holdings account for 2.7% of the portfolio.

Acrospire Investment Management withdrew a net $16.8M in Q2 2017, closing 739 positions and reducing 830 holdings. Its most notable exit was Bunge Global, an estimated $285K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Acrospire Investment Management opened a new position in Procter & Gamble worth $418K.

  • Acrospire Investment Management's largest Q2 2017 buy was Procter & Gamble: 4,800 shares worth $418K.
  • Acrospire Investment Management added most to General Mills in Q2 2017, an estimated $314K increase.
  • Acrospire Investment Management's biggest Q2 2017 reduction was Navios Maritime Acquisition Corporation, cutting an estimated $1.35M.
  • Acrospire Investment Management fully exited Bunge Global in Q2 2017, selling an estimated $285K.
  • Acrospire Investment Management's ten largest holdings make up 2.7% of its $107M portfolio in Q2 2017.
  • Acrospire Investment Management opened 705 new positions and closed 739 in Q2 2017.
  • Acrospire Investment Management's portfolio value fell 12% quarter-over-quarter to $107M.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.